Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07048600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brief Trial of ACT-i for Adults With Chronic Insomnia

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2026 (before its estimated October 15, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 4 months later across 2 updates May 2026 → Oct 15, 2026
See other at-risk trials from Babes-Bolyai University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 15, 2026 to Oct 15, 2026
    • Study completion pushed from Aug 30, 2026 to Oct 30, 2026
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 6 of 7 entries
  2. Primary completion pushed from May 2026 to Aug 15, 2026
    • Study completion pushed from Jun 2026 to Aug 30, 2026
    v3
  3. Enrollment target: 128 to 76v2 Show 4 more changesShow less
    • Primary completion date: Jul 2025 to May 2026
    • Study completion date: Oct 2025 to Jun 2026
    • Start date: Jun 1, 2025 to May 23, 2025
    • Secondary endpoints: 6 to 7
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Babes-Bolyai University
13 trials monitored
See 1 trial at risk
Anxiety
3,263 trials monitored
See 159 trials at risk
This is a prospective, randomized-controlled trial that assesses the efficacy of a brief Acceptance and Commitment Therapy (ACT-i), compared to an attentional control group, in adults with chronic insomnia. The interventions will be evaluated for their impact on insomnia severity, cognitive function, depression, anxiety, psychological flexibility, and sleep beliefs - measured before treatment, two weeks after and at a three-month follow-up.
Trial Details
NCT Number NCT07048600
Lead Sponsor Babes-Bolyai University
Conditions
(from sponsor)		 Chronic Insomnia
Related terms Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov